Article
Pathogenic or not? Assessing the clinical relevance of copy number variants.
Clinical genetics - 1 Nov 2013
Hehir-Kwa J Y, Pfundt R, Veltman J A, de Leeuw N
Abstract excerpt
The availability of commercially produced genomic microarrays has resulted in the wide spread implementation of genomic microarrays, often as a first-tier diagnostic test for copy number variant (CNV) screening of patients who are suspected for chromosomal aberrations. Patients with intellectual disability (ID) and/or multiple congenital anomalies (MCA) were traditionally the main focus for this microarray-based...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
